SCHEMBL29555753

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	8/20	0.63

▸	PTH1R	Q03431	1/20	0.59

▸	GCGR	P47871	1/20	0.59

▸	GIPR	P48546	1/20	0.59

▸	KISS1R	Q969F8	11/20	0.59

▸	ECE1	P42892	1/20	0.58

▸	MUS81	Q96NY9	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31647884	0.96	GLP1R (0.62)	GLP1RGCGRGIPRKISS1RECE1
SCHEMBL31688342	0.95	GLP1R (0.63)	GLP1RGCGRGIPRKISS1RECE1
SCHEMBL29556314	0.94	GLP1R (0.61)	GLP1RKISS1R
SCHEMBL29555569	0.93	KISS1R (0.65)	GLP1RKISS1R
SCHEMBL29555261	0.92	GLP1R (0.60)	GLP1RGCGRGIPRKISS1RECE1
SCHEMBL29556593	0.92	GLP1R (0.66)	GLP1RPTH1RGCGRGIPRKISS1R
SCHEMBL29555649	0.92	GLP1R (0.66)	GLP1RPTH1RGCGRGIPRKISS1R
SCHEMBL29554962	0.92	GLP1R (0.66)	GLP1RPTH1RGCGRGIPRKISS1R
SCHEMBL29556183	0.92	GLP1R (0.66)	GLP1RPTH1RGCGRGIPRKISS1R
SCHEMBL29555658	0.92	GLP1R (0.66)	GLP1RPTH1RGCGRGIPRKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3818070-B1	SYNTHETIC PEPTIDES, PRODRUGS, PHARMACEUTICAL COMPOSITIONS AND USES	BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS (BR)	2026-03-11	—	—	EP	disclosed
CN-112654634-B	Synthetic peptides, prodrugs, pharmaceutical compositions and uses	生物医药产品开发公司	2022-05-27	—	—	CN	disclosed